Anticoagulation Forum/X
Jun 2, 2025, 08:35
Refining Thrombophilia Testing: New ACE Rapid Resource Offers Practical Guidance for Clinicians – Anticoagulation Forum
The Anticoagulation Forum has released a new ACE Rapid Resource shared on X, offering concise, evidence-based guidance on thrombophilia testing, built on the most current clinical guidelines. This resource supports clinicians across a range of scenarios—from determining the appropriateness of testing to accurately interpreting results.
“Key features include:
Indications for Testing: Defines clinical contexts where thrombophilia testing is justified, helping to prevent overuse and reduce diagnostic errors.
Interpretation Framework: Offers expert-driven explanations on how to interpret test results in the presence of confounding factors such as acute illness, medications, pregnancy, or hormonal therapy.
Clinical Application: Equips healthcare providers with actionable insights to improve diagnostic accuracy and enhance patient outcomes in suspected thrombophilia.
This resource is a collaboration led by Greg Hadlock, PharmD, PhD, with clinical input from Jean Connors, MD, and an expert panel, and is part of a growing library of high-quality tools offered by the Anticoagulation Forum.”
Access the full resource on ACE Rapid Resource – Thrombophilia Testing․
Thrombophilia Testing: Key Insights from the ACE Rapid Resource
The Anticoagulation Forum’s ACE Rapid Resource offers a streamlined, evidence-based summary to guide clinicians on when and how to perform thrombophilia testing. It emphasizes:
- Appropriate indications to avoid unnecessary testing and misinterpretation.
- Result interpretation in the context of confounding factors such as acute illness, medications, and pregnancy.
- Clinical integration to support accurate diagnosis and optimize patient outcomes.
- This resource reflects current best practices and is intended to enhance decision-making in complex thrombotic risk assessments.
Discover the latest expert insights in Hemostasis Today.
-
Oct 21, 2025, 06:59Samwel Mikaye: Polycythemia and the Risk of Blood Clots
-
Oct 21, 2025, 06:58Samuel Nweke: Interpreting D-Dimer Results
-
Oct 21, 2025, 05:20Ewa Fiorentino Rozek: APS - When “Unprovoked” Clots And Pregnancy Loss Connect
-
Oct 21, 2025, 03:503 Questions With Abigail Ajanel Gomez – Touch Haematology Future Leader 2025
-
Oct 21, 2025, 01:57Mohamed Reda: Clotting Factors — The Key Players in Blood Coagulation
-
Oct 22, 2025, 10:35Evaluating a Novel Human Fibrinogen Concentrate (BT524) for Congenital Fibrinogen Deficiency
-
Oct 22, 2025, 09:37Jurjen Krommenhoek and Colleagues Propose a Clinical Care Pathway for Major Bleeding Survivors
-
Oct 22, 2025, 09:32Ishac Nazy: Proud Moment For Our Team!
-
Oct 22, 2025, 09:16Richard Benjamin Shares Results of The ReCePI Phase III Clinical Study
-
Oct 21, 2025, 11:13Hanny Al Samkari's Commentary on Iron Deficiency Anemia in Inherited Bleeding Disorders
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 21, 2025, 06:43Could Gene Therapy Offer Lasting Quality of Life for People with Hemophilia B?
-
Oct 21, 2025, 06:18Katerina Akassoglou Receives Zenith Fellows Award to Advance Alzheimer’s Research
-
Oct 16, 2025, 06:07ClearPlasma - A New Breakthrough in Stopping Life-Threatening Bleeds
-
Oct 22, 2025, 10:46Conversation with Ferran Nadeu – Touch Haematology Future Leader 2025
-
Oct 22, 2025, 10:32Lynn Malec - The New Director of the CCBD and Pharmacy at Children's Wisconsin
-
Oct 22, 2025, 09:41Deanna Joseph: Feeling Inspired and Deeply Grateful After Attending the 2025 HTRS SEARCH Workshop
-
Oct 22, 2025, 08:41Maryum Salim Reflects on Her Experience at the HTRS SEARCH Workshop
-
Oct 22, 2025, 08:36Emilya Huseynova to Speak at AABB 2025
Oct 22, 2025, 10:46
Oct 22, 2025, 10:32
Oct 22, 2025, 09:32
Oct 22, 2025, 09:16
Oct 22, 2025, 08:41
Oct 22, 2025, 08:36